Genetic Testing for Breast Cancer
Genetics can impact your cancer risk. Emerson provides genetic testing and high risk screening for patients who want to know their risk to take steps to prevent breast cancer and ensure it is found at the earliest, most treatable stages.
Genetic Testing for Breast Cancer
Genetic testing helps doctors understand the genetic causes of breast cancer, allowing for more personalized and targeted treatments. It involves analyzing the tumor’s DNA to assess whether a patient is at high or low risk of cancer returning. If a patient is at low risk, they may not need chemotherapy.
Women diagnosed with breast cancer are generally offered genetic testing if they are under 50 or have a family history of mutations in the BRCA1 or BRCA2 genes. These mutations can increase the risk of developing breast cancer (56–87%), ovarian cancer (27–44%), and pancreatic cancer (2–4%). Men with these mutations also face higher risks for breast, pancreatic, and prostate cancer.
A medical oncologist manages genetic testing and helps patients understand the results. If a patient tests positive for a BRCA mutation, they may need to take steps to lower their future cancer risk. Preventive options include surgery to remove both breasts (prophylactic mastectomy) and ovaries or more frequent screenings for breast and ovarian cancer.
For more information or to schedule testing, call 978-287-3547.
Location
-
Emerson Health Surgery
131 Old Road to Nine Acre Corner
Suite 500
Concord, MA 01742